1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 1,267 results.

Thumbnail for T-Cell Exhaustion-Based Transcriptomic Signature Predicts Multiple Myeloma Survival and Reveals Montelukast as an Immunomodulatory Repositioning Candidate

MM - 1088

T-Cell Exhaustion-Based Transcriptomic Signature Predicts Multiple Myeloma Survival and Reveals Montelukast as an Immunomodulatory Repositioning Candidate

Ecem Kalemoglu

Poster Presenter: Ecem Kalemoglu

MM - 1091

Therapeutic Targeting of SETD8 Suppresses Multiple Myeloma Growth Through the IRF4/MYC Axis

Rudra Prasad Dutta

Poster Presenter: Rudra Prasad Dutta

$Thumbnail for Trial in Progress: QUINTESSENTIAL-2, a Phase 3 Study of Arlocabtagene Autoleucel vs Standard of Care in Adult Patients With Relapsed/Refractory Multiple Myeloma Exposed to Lenalidomide$

MM - 1092

Trial in Progress: QUINTESSENTIAL-2, a Phase 3 Study of Arlocabtagene Autoleucel vs Standard of Care in Adult Patients With Relapsed/Refractory Multiple Myeloma Exposed to Lenalidomide

Eyal Lebel

Poster Presenter: Eyal Lebel

Thumbnail for Racial and Ethnic Disparities in Radiation Therapy Utilization Among Patients With Multiple Myeloma and Bone Metastasis: A Real-World Analysis Using TriNetX

MM - 1098

Racial and Ethnic Disparities in Radiation Therapy Utilization Among Patients With Multiple Myeloma and Bone Metastasis: A Real-World Analysis Using TriNetX

Juhi Ardeshna-Chovatiya

Poster Presenter: Juhi Ardeshna-Chovatiya

$Thumbnail for Impact of Dose Modifications on Efficacy Outcomes With Belantamab Mafodotin in Relapsed/Refractory Multiple Myeloma: Insights From the DREAMM-7 Third-Line or Later Proteasome Inhibitor/Immunomodulatory Agent-Exposed Subgroup$

MM - 1100

Impact of Dose Modifications on Efficacy Outcomes With Belantamab Mafodotin in Relapsed/Refractory Multiple Myeloma: Insights From the DREAMM-7 Third-Line or Later Proteasome Inhibitor/Immunomodulatory Agent-Exposed Subgroup

Al-Ola Abdallah

Poster Presenter: Al-Ola Abdallah

Video

MM - 1107

Mental Health and Malignancy: Real-World Associations Between Early-Onset Multiple Myeloma and Mental Illness

Danielle Thor

Poster Presenter: Danielle Thor

$Thumbnail for Arlocabtagene Autoleucel in Patients With Heavily Pretreated Relapsed/Refractory Multiple Myeloma: Final Analysis From the Phase 1 Study$

MM - 1119

Arlocabtagene Autoleucel in Patients With Heavily Pretreated Relapsed/Refractory Multiple Myeloma: Final Analysis From the Phase 1 Study

Susan Bal

Poster Presenter: Susan Bal

MM - 1126

Closing the Gap or Widening the Divide? Racial and Sex Disparities in Multiple Myeloma Mortality in the United States, 1999-2020

Neha Pillai Vinod

Poster Presenter: Neha Pillai Vinod

Thumbnail for CRAB-Related Complication Burden in Multiple Myeloma Hospitalizations: Mortality, Organ Support, and Resource Utilization in the National Inpatient Sample Database

MM - 1133

CRAB-Related Complication Burden in Multiple Myeloma Hospitalizations: Mortality, Organ Support, and Resource Utilization in the National Inpatient Sample Database

Priyanka Nagdev

Poster Presenter: Priyanka Nagdev